ZoBio will attend the 9th RSC-BMCS Fragment-based Drug Discovery meeting which will take place in Cambridge on 3 – 5 March 2024.
The meeting will focus on case studies in Fragment-based Drug Discovery that have delivered compounds to late stage medicinal chemistry, preclinical or clinical programs. ZoBio will be represented by Pim de Vink (Scientist, Assay Development and Screening) who will present poster Screening for Fragment Molecular Glues.
We are convinced that great scientific program and fantastic atmosphere will deliver a truly memorable conference!
Starting from Sunday October 12th the ZoBio team participated in the 31th Protein Structure Determination in Industry meeting, which was held at the Wellcome Genome Campus, Hinxton Cambridge. This year’s meeting was organized jointly by the EMBL-EBI and GSK, supported by Hg3 Conferences. The scientific talks clustered around the following major themes:
- Synergy of structural and computational approaches
- Structural biology across modalities
- Beyond purified protein
- Integration of data across techniques
Our scientists: Inês Justo and Marc Morgan presented the poster: Tailor-made Structural Biology at ZoBio, highlighting various studies we have performed across our Structural Biology platforms.
During the conference our colleagues had a great opportunity to connect with fellow researchers and learn more about the latest advancements.
Our team participated in Discovery on Target, the industry’s preeminent event on novel drug targets and technologies for drug discovery professionals. The conference highlighted advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents, ranging from biologics to small molecules.
On Tuesday September 25th ZoBio CEO, Gregg Siegal presented the lecture: ‘The Art of Crafting a Mode of Action: Site Selective Hit Discovery”.
During the entire conference the ZoBio team was present at booth #325 answering the questions about our capabilities.
From 10 to 13 September the ZoBio team participated in SCI/RSC 22nd Medicinal Symposium in Cambridge.
This symposium, is Europe’s premier biennial Medicinal Chemistry event, focusing on first disclosures and new strategies in Medicinal Chemistry.
ZoBio was represented by Denise Tsagris, Henri van Son and Kasia Borsuk. It was a great opportunity to learn from the leaders, engage with the scientific community, and stay updated on the latest advancements in the field of medicinal chemistry.